Pushing the limits: Infinite Machine's Olto is barely a bicycle
THE SO WHAT
Blurring the line between e-bikes and scooters is a regulatory and UX play, not just a design choice—form factor is being used to route around moped rules while still tapping bike lanes and parking norms. If you operate in urban mobility, assume more vehicles will live in these gray zones and plan for fragmented rules, insurance, and infrastructure expectations.
READ THE SOURCE
MORE FROM THE WIRE
Tech & InnovationCarlyle CFO Plouffe on M&A Market, Private Credit and AI
If Carlyle is still exiting broadly across Japan, Europe, and the US while calling private credit “tricky,” it suggests liquidity is available but selective. Operators should assume buyers will lean harder on AI upside in their underwriting models — you’ll need a concrete automation and margin story to clear IC.
Tech & Innovation'It is not a form of advertising': BMW defends Spider-Man pop-up ads that have infuriated customers
In-car Spider-Man promos framed as “not advertising” show how quickly connected vehicles are becoming contested ad surfaces. Any OEM or mobility platform experimenting with in-cabin messaging needs a clear consent and control model — or risk turning UX innovation into a brand liability.
Tech & InnovationDisney Climbs on Profit Beat; AMD Falls on Underwhelming Forecast | Stock Movers
Disney beating profit expectations while a major chip vendor underwhelms on AI-driven revenue is a reminder that capex narratives and realized demand can diverge quarter to quarter. If your roadmap assumes infinite cheap accelerators, build in scenarios where supply tightens or pricing doesn’t fall as fast as the hype.
Hedge fund manager Gavin Baker says investors have been too quick to judge Big Tech's AI spending
If public-market investors are already re-rating Big Tech’s AI capex as productive rather than reckless, the window for smaller players to raise on “infra story alone” is narrowing. Startups pitching heavy AI infrastructure should show line-of-sight to unit economics, not just scale.